CAMBRIDGE, Md., Nov. 17, 2020 /PRNewswire/ -- OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat…
Super UserNovember 23, 2020
For the sixth consecutive year, the University of Maryland (UMD) earned a top 10 ranking in The Princeton Review’s annual…
Super UserNovember 23, 2020
SR One, a trans-Atlantic biotech venture capital firm, announced today the close of its first independent fund, having recently completed…
Super UserNovember 23, 2020
The results of this year’s McKinsey Global Survey on artificial intelligence (AI) suggest that organizations are using AI as a…
Super UserNovember 23, 2020
With COVID-19, we’ve seen our preparedness response tested, and the question remains, how can we be better prepared to protect…
Super UserNovember 23, 2020
In seeking to combat emerging infectious diseases and other 21st century health threats, the path to better prepared, protected, and…
Super UserNovember 23, 2020
BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA),…
Super UserNovember 23, 2020
South Korea’s leading biologics companies will invest hundreds of billions of won to building additional plants that would push the…
Super UserNovember 23, 2020
ROCKVILLE, Md. & DURHAM, N.C.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid…
Super UserNovember 23, 2020